Delivery Order SPE2DB22D1106-SPE2DB25FFHM4
- Not listed
- The Defense Logistics Agency awarded a $41,719.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for Tobi Podhaler 28 mg inhalable capsules (56-unit dose packages) on August 19, 2025, with completion targeted for August 20, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pediatric and adult cystic fibrosis treatment, positioning the pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,972.30, is for the supply of the pharmaceutical product Tobi Podhaler 28 mg inhalation capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,745.92, is for the delivery of 4,562,406,339 units of TOBI PODHALER 28 MG INHALE CAP UD 56S, with an ultimate completion date of October 6, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,186.01 firm fixed-price delivery order is for the supply of 4562300741 Tobi Podhaler 28 mg inhalation capsules. The contract has a completion date of September 26, 2023 and does not include a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,075.64 firm fixed-price delivery order is for the supply of 4,566,359,280 units of the medication Tobi Podhaler 28 mg inhalation capsules. The contract has an ultimate completion date of November 7, 2024 and was awarded on November 6, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
- This is a delivery order contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $41,392.19, is for the delivery of Tobi Podhaler 28 mg inhalation capsules. The contract has a firm fixed price pricing type and an ultimate completion date of September 28, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp has an Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,819.01, is for the delivery of 4,566,250 units of the TOBI PODHALER 28 MG INHALE CAP UD 56S medical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $18,676.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tobi Podhaler 28 mg inhalation capsules and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the...
- The federal contract award SPE2DB22D3004|SPE2DB24FPS54 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $15,245.43 firm fixed price delivery order is for the supply of 4,564,030,051 units of the pharmaceutical product Tobi Podhaler 28 mg Inhalation Capsules. This award is part of a larger $999,999,999.00 indefinite delivery contract held by Amerisourcebergen Drug Corp to provide a...
- The Defense Logistics Agency awarded a $24,342 delivery order to Amerisourcebergen Drug Corporation for 56 units of 28 mg Tobramycin inhalation capsules to be delivered to a location in Conshohocken, Pennsylvania. The firm fixed price order is being funded by the Defense Logistics Agency and will provide Tobramycin inhalation capsules, used to treat cystic fibrosis, to support the agency's medical supply needs. Amerisourcebergen Drug Corporation will perform the order from its corporate...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHM4Delivery Order
The Defense Logistics Agency awarded a $28,423.85 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tobi Podhaler 28 mg inhalable capsules (56-count unit dose). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is set for completion by September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location in the same city. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a diverse portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems and other federal healthcare programs. This order for Tobi Podhaler—a tobramycin inhalation solution used in respiratory infection treatment—exemplifies the company's role in fulfilling specialized pharmaceutical procurement requirements across multiple therapeutic domains for the Defense Health Agency and broader Department of Defense healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.4k | 9/8/25 |